Income Taxes	6 Months Ended
Dec. 29, 2012
Income Tax Disclosure [Abstract]
Income Taxes [Text Block]	INCOME TAXES In the three and six months ended December 29, 2012, the Company recorded an income tax provision of $38.1 million and $69.9 million, respectively, compared to an income tax provision of $28.8 million and $63.6 million in the three and six months ended December 31, 2011, respectively. The Company's federal statutory tax rate is 35%. The Company's income tax provision for the three and six months ended December 29, 2012 and December 31, 2011 was lower than the amount computed by applying the statutory tax rate primarily because the earnings of the foreign subsidiaries were taxed at lower rates. The Company's income tax provision for the three and six months ended December 29, 2012 included a $21.4 million discrete tax charge for research and development expenses of a foreign subsidiary for which no tax benefit is available. On January 2, 2013, the President signed into law The American Taxpayer Relief Act of 2012, which extended the research tax credit for two years from January 1, 2012 to December 31, 2013. As a result of the retroactive extension back to January 1, 2012, we expect to recognize a one-time benefit of $7.6 million for research tax credits earned in the fiscal year 2012 and first two quarters of fiscal year 2013. This benefit will be recognized in the third quarter of fiscal year 2013, which is the quarter in which the legislation that extended the research tax credit was enacted. In fiscal year 2012 the U.S. Internal Revenue Service commenced an audit of the Company's federal corporate income tax returns for fiscal years 2009 through 2011, which is still ongoing.

Income Taxes

6 Months Ended

Dec. 29, 2012

INCOME TAXES

In the three and six months ended December 29, 2012, the Company recorded an income tax provision of $38.1 million and $69.9 million, respectively, compared to an income tax provision of $28.8 million and $63.6 million in the three and six months ended December 31, 2011, respectively.

The Company's federal statutory tax rate is 35%. The Company's income tax provision for the three and six months ended December 29, 2012 and December 31, 2011 was lower than the amount computed by applying the statutory tax rate primarily because the earnings of the foreign subsidiaries were taxed at lower rates. The Company's income tax provision for the three and six months ended December 29, 2012 included a $21.4 million discrete tax charge for research and development expenses of a foreign subsidiary for which no tax benefit is available.

On January 2, 2013, the President signed into law The American Taxpayer Relief Act of 2012, which extended the research tax credit for two years from January 1, 2012 to December 31, 2013. As a result of the retroactive extension back to January 1, 2012, we expect to recognize a one-time benefit of $7.6 million for research tax credits earned in the fiscal year 2012 and first two quarters of fiscal year 2013. This benefit will be recognized in the third quarter of fiscal year 2013, which is the quarter in which the legislation that extended the research tax credit was enacted.

In fiscal year 2012 the U.S. Internal Revenue Service commenced an audit of the Company's federal corporate income tax returns for fiscal years 2009 through 2011, which is still ongoing.